HOME  | COMPANY| PIPELINE | PARTNERING | NEWS | CAREERS |
Company
Management
Board of Directors
Scientific Advisory Committee
Contact

 

Vin Bhalani - Director, Chairman

Vin is a co-founder of Sidmak Laboratories (now Pliva USA) which grew to a company with sales in excess of $150 MM before it was sold to Sobel in 1997/98, and eventually acquired by Pliva in 1999. While at Sidmak, Vin was responsible for all of the Technical Operations activities of the company. Today, Vin continues to be involved in other successful entrepreneurial ventures; Abeille being his first foray back into the pharmaceutical sector after his tenure with Sidmak Laboratories/Sobel/Pliva.

 

Suresh B. Borsadia - President & CEO, Director, Founder

Suresh has more than fourteen years experience in the pharmaceutical and drug delivery industry, with expertise and experience in R&D, business and corporate development activities. Suresh has a demonstrated record of successfully managing multiple projects and building R&D organizations in early stage companies. Prior to founding Abeille Pharmaceuticals, he was with Lavipharm for seven years, where he played a leading role in the company's R&D, in-licensing, and out-licensing activities. While at Lavipharm, he was part of the Senior Management team involved in M&A and fund raising activities. Prior to Lavipharm he worked at TheraTech, Inc., (now Watson Pharmaceuticals) and Bertek Inc., (now Mylan Technologies, a Division of Mylan Labs.).

 

Kalpana Patel, Ph.D. - VP, Strategic Planning & Alliance Management, Director

Kalpana has more than twelve years of experience in the pharmaceutical industry. She has led pre-formulation, formulation, process development and validation initiatives for a broad range RX, RX to OTC switches, OTC products and medical devices. Kalpana most recently was the Pipeline Development Director for Johnson & Johnson Consumer Companies. During her tenure at J&J, she held leadership responsibilities involving product development, life-cycle management, and was involved in advisory meetings with thought leaders. In addition, she was actively involved in interaction with global regulatory bodies. While at J&J, she also founded the Johnson & Johnson community of product/process development.

 

 

 



 

© Abeille Pharmaceuticals, Inc 2004 - 2012